Dermatology Times March 2025 Print Recap

The March issue of Dermatology Times includes a collection of thought-provoking articles and topics ranging from the potential role of CBD in therapeutic dermatology to a discussion on the challenges of pigmentary disorders in women across the Fitzpatrick skin spectrum. Be sure to read the highlights from the issue below. Also, don’t miss a moment of Dermatology Times by signing up for our eNewsletters and subscribing to receive the free print issue and supplement each month.

Do CBD Products Belong in Therapeutic Dermatology?

CBD, an abbreviation for cannabidiol, is showing up everywhere in skin care products. In 2025, the CBD skin care market is expected to hit $1.7 billion, which is more than the annual sales of most prescription dermatology drugs. Are patients spending their money wisely on CBD products or wasting valuable resources?

Continue Reading

Addressing the Challenges of Pigmentary Disorders in Women Across the Fitzpatrick Skin Spectrum

Pigmentary disorders, notably melasma and hyperpigmentation, disproportionately affect women, particularly those with skin of color. Melasma is estimated to affect women 9 times more than men and has a prevalence rate of 15% to 50% in pregnant women, whereas postinflammatory hyperpigmentation (PIH) affects approximately 56% of women. Women with higher Fitzpatrick skin types are at a greater risk of developing melasma and PIH, particularly Asian, Latina, and Black women.

Valerie Harvey, MD, MPH, FAAD, a board-certified dermatologist specializing in pigmentary disorders and dermatologic conditions in patients with skin of color, shared key insights for clinicians on the diagnosis, treatment, and broader impact of these conditions in women and patients with darker skin types.

Continue Reading

Bridging the Gender Gap: Women Leading the Way

As treatment guidelines, medical treatments, and patient perspectives change, so too has the demographic makeup of the dermatology specialty.

In 1970, the Association of American Medical Colleges estimated that women comprised just 6.9% of the dermatology workforce. Since then, a 2021 International Journal of Women’s Dermatology study estimates that number has increased more than 7-fold, with women now making up 49.9% of the specialty. This number is projected to steadily rise; for more than 20 years, women have represented the majority of dermatology residents (> 60%), indicative of a continually narrowed gap.

Dermatology Times recognizes the importance of continually highlighting the passion and achievements in dermatology, with female researchers, leaders, and clinicians playing an important role in dermatological innovation. Although the specialty has come a long way in diversification, there is still much progress to be made.

Continue Reading

Reshaping Dermatology: The Enduring Impact of COVID-19

On March 11, 2020, the World Health Organization (WHO) declared the outbreak of SARS-CoV-2 and the associated disease (COVID-19) a global pandemic. Just a few days later, on March 15, states began to implement lockdown orders. Although the pandemic officially ended on May 11, 2023, its reverberations continue to be felt across the entire field of medicine. As we mark the fifth anniversary of this once-in-a-lifetime event, it is evident that dermatology, a specialty heavily reliant on both physical examination and visual-textural context, has experienced profound and lasting changes. Three long-term effects on dermatology have emerged across academia and private practice.

Continue Reading

Click here to view all articles in the March issue